These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
342 related articles for article (PubMed ID: 34644216)
41. A pairwise immune gene model for predicting overall survival and stratifying subtypes of colon adenocarcinoma. Jiang Z; Xu J; Zhang S; Lan H; Bao Y J Cancer Res Clin Oncol; 2023 Sep; 149(12):10813-10829. PubMed ID: 37316691 [TBL] [Abstract][Full Text] [Related]
42. Identification of necroptosis-related genes for predicting prognosis and exploring immune infiltration landscape in colon adenocarcinoma. Wang Y; Lin MG; Meng L; Chen ZM; Wei ZJ; Ying SC; Xu A Front Oncol; 2022; 12():941156. PubMed ID: 36505813 [TBL] [Abstract][Full Text] [Related]
43. A Novel Glycolysis and Hypoxia Combined Gene Signature Predicts the Prognosis and Affects Immune Infiltration of Patients with Colon Cancer. Mao G; Wu J; Cui H; Dai L; Ma L; Zhou Z; Liang B; Zhang S; Lin S Int J Gen Med; 2022; 15():1413-1427. PubMed ID: 35185344 [TBL] [Abstract][Full Text] [Related]
44. Development and Validation of a Prognostic Model based on 11 E3-related Genes for Colon Cancer Patients. JIang W; Dong J; Zhang W; Huang Z; Guo T; Zhang K; Jiang X; Du T Curr Pharm Des; 2024; 30(12):935-951. PubMed ID: 38898815 [TBL] [Abstract][Full Text] [Related]
45. Establishment and validation of a prognostic model based on HRR-related lncRNAs in colon adenocarcinoma. Tang X; Lin Y; He J; Luo X; Liang J; Zhu X; Li T World J Surg Oncol; 2022 Mar; 20(1):74. PubMed ID: 35264195 [TBL] [Abstract][Full Text] [Related]
46. Identification and validation of the prognostic signature of a novel demethylation-related gene associated with the clinical features of colon cancer. Kang K; Huang H; Chen Z Int Immunopharmacol; 2024 Sep; 139():112798. PubMed ID: 39079198 [TBL] [Abstract][Full Text] [Related]
47. Construction of a prognostic model based on genes associated with mitochondrial energy metabolic pathway in colon adenocarcinoma and its clinical significance. Zhang X; Liang C; Zhou B; Pang L J Mol Recognit; 2023 Aug; 36(8):e3044. PubMed ID: 37322568 [TBL] [Abstract][Full Text] [Related]
48. System analysis based on the ER stress-related genes identifies WFS1 as a novel therapy target for colon cancer. Yang X; Zhang C; Yan C; Ma L; Ma J; Meng X Aging (Albany NY); 2022 Nov; 14(22):9243-9263. PubMed ID: 36445321 [TBL] [Abstract][Full Text] [Related]
49. Prediction and identification of immune genes related to the prognosis of patients with colon adenocarcinoma and its mechanisms. Chen S; Cao GD; Wei W; Yida L; Xiaobo H; Lei Y; Ke C; Chen B; Xiong MM World J Surg Oncol; 2020 Jun; 18(1):146. PubMed ID: 32600423 [TBL] [Abstract][Full Text] [Related]
50. Comprehensive analysis of the prognosis, tumor microenvironment, and immunotherapy response of SDHs in colon adenocarcinoma. Nan H; Guo P; Fan J; Zeng W; Hu C; Zheng C; Pan B; Cao Y; Ge Y; Xue X; Li W; Lin K Front Immunol; 2023; 14():1093974. PubMed ID: 36949947 [TBL] [Abstract][Full Text] [Related]
51. The anoikis-related gene signature predicts survival accurately in colon adenocarcinoma. Hu G; Li J; Zeng Y; Liu L; Yu Z; Qi X; Liu K; Yao H Sci Rep; 2023 Aug; 13(1):13919. PubMed ID: 37626132 [TBL] [Abstract][Full Text] [Related]
52. Identification of a novel glycolysis-related gene signature for predicting metastasis and survival in patients with lung adenocarcinoma. Zhang L; Zhang Z; Yu Z J Transl Med; 2019 Dec; 17(1):423. PubMed ID: 31847905 [TBL] [Abstract][Full Text] [Related]
53. Exploring the prognostic function of TMB-related prognostic signature in patients with colon cancer. Zhao Y; Liang X; Duan X; Zhang C BMC Med Genomics; 2023 May; 16(1):116. PubMed ID: 37237274 [TBL] [Abstract][Full Text] [Related]
54. 5mC-Related lncRNAs as Potential Prognostic Biomarkers in Colon Adenocarcinoma. Huang Y; Huang H; Wang Y; Liu H; Huang Y Biology (Basel); 2022 Feb; 11(2):. PubMed ID: 35205097 [TBL] [Abstract][Full Text] [Related]
55. Construction of disulfidptosis-related lncRNA signature for predicting the prognosis and immune escape in colon adenocarcinoma. Chen P; Yu J; Luo Q; Li J; Wang W BMC Gastroenterol; 2023 Nov; 23(1):382. PubMed ID: 37946148 [TBL] [Abstract][Full Text] [Related]
56. A novel prognostic signature contributes to precision treatment in colon adenocarcinoma with KRAS mutation. Dong W; Zhang H; Li Q; Guan N; Yun C; Zhao H; Zhang F; Zeng Z; Hu Y; Li Q; Yang J; Ma Z; Chen M; Xiao W Eur J Cancer Prev; 2023 Nov; 32(6):557-565. PubMed ID: 37310401 [TBL] [Abstract][Full Text] [Related]
57. Analysis of Interleukin-1 Signaling Alterations of Colon Adenocarcinoma Identified Implications for Immunotherapy. Zhou X; Liu Y; Xiang J; Wang Y; Wang Q; Xia J; Chen Y; Bai Y Front Immunol; 2021; 12():665002. PubMed ID: 34367132 [TBL] [Abstract][Full Text] [Related]
58. Identification of a novel prognostic signature composed of 3 cuproptosis-related transcription factors in colon adenocarcinoma. Zhou L; Zhang Y; Xu Y; Jiang T; Tang L Genes Genomics; 2023 Aug; 45(8):1047-1061. PubMed ID: 37318704 [TBL] [Abstract][Full Text] [Related]
59. Identification of candidate genes encoding tumor-specific neoantigens in early- and late-stage colon adenocarcinoma. Wang C; Xue W; Zhang H; Fu Y Aging (Albany NY); 2021 Jan; 13(3):4024-4044. PubMed ID: 33428592 [TBL] [Abstract][Full Text] [Related]
60. Development and validation of a novel glycolysis-related risk signature for predicting survival in pancreatic adenocarcinoma. Li A; Hou S; Chen J; Jiang Y Clin Chim Acta; 2021 Jul; 518():156-161. PubMed ID: 33775699 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]